Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$20.14
-0.49-2.38%
At close: Dec 15, 4:00 PM EST
$20.01
-0.13-0.64%
After Hours: 4:14 PM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Innoviva (INVA) stock?
You can purchase shares of Innoviva (NASDAQ:INVA) through any online brokerage.
Who are Innoviva (INVA) competitors?
Other companies in Innoviva’s space includes: Atai Beckley NV (NASDAQ:ATAI), Xeris Biopharma Holdings Inc (NASDAQ:XERS), Phibro Animal Health Corp (NASDAQ:PAHC), Rapport Therapeutics Inc (NASDAQ:RAPP) and ANI Pharmaceuticals Inc (NASDAQ:ANIP).
What is the forecast, or price target, for Innoviva (INVA) stock?
Innoviva has a consensus price target of $28.56.
What is the current price for Innoviva (INVA)?
The stock price for Innoviva (NASDAQ: INVA) is $20.0102 last updated December 15, 2025 at 4:14 PM EST.
Does Innoviva (INVA) pay a dividend?
There are no upcoming dividends for Innoviva.
When is Innoviva (NASDAQ:INVA) reporting earnings?
Innoviva does not have any upcoming earnings scheduled.
Is Innoviva (INVA) going to split?
There is no upcoming split for Innoviva.
What sector and industry does Innoviva (INVA) operate in?
Innoviva is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
